Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/DLB
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Dolby Laboratories, Inc. (DLB) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

DLB trades at $57.65, showing modest daily gains of 0.31%. The stock exhibits bearish technical signals with recent earnings beating expectations in three consecutive quarters. Strong profitability metrics include an 87.61% gross margin and 16.7% net income margin. Recent leadership transition with Marc Whitten as new CEO and expansion of Dolby OptiView platform indicate strategic developments. Cash flow improved significantly in 2025 with $216M net cash flow versus negative trends in prior years.
DLB presents a mixed outlook with analyst consensus target of $90.33 suggesting 57% upside potential, though technical indicators remain bearish. The company maintains strong fundamentals but faces execution risks amid licensing volatility and competitive pressures. Revenue stability around $1.3B with declining profit margins warrants monitoring of Q3 2026 results and new growth initiatives.
Read full analysis

Key Stats

  • Market Cap
    $5.37B
  • Volume
    846,904
  • Sector
    Technology
  • 52W High
    $72.67
  • 52W Low
    $48.51
  • Typical Hold Time
    97 Days
  • Enterprise Value
    $4.75B
  • Div Yield
    2.51%
  • Trading Activity
    100% Sell | 0% Buy
$57.07
52W Low: $48.51
14 Jul 2026
52W High: $72.67
06 Oct 2025

Track Dolby Laboratories, Inc. (DLB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Dolby Laboratories, Inc. has traded between a low of $48.51 and a high of $72.67, highlighting its annual price range. Buy and sell Dolby Laboratories, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Most Recent News

Content is generated by Aura AI

Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Jaguar Health (JAGX) surged over 1,150% after the FDA granted fee waivers for its drugs Mytesi and Canalevia-CA1, signaling regulatory support. Greenland Mines (GRML) rose nearly 50% amid growing investor interest linked to U.S.-Greenland security de...

Market News
2 hours ago
Alex Lavoie
Bullish
news icon
Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

The market experienced a downturn with significant losses among key stocks. New Fortress Energy dropped 24.7% amid ongoing volatility in energy sectors, while Xanadu Quantum Technologies fell 21.7% reflecting sensitivity in quantum stocks to commerci...

Market News
2 hours ago
Alex Lavoie
Bearish
news icon
Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

Fulcrum Therapeutics faces investigation after stock halves due to halted sickle cell drug program.

Fulcrum Therapeutics announced it stopped development of its sickle cell disease drug, pociredir, following FDA concerns about cancer risks linked to similar drugs. This led to a 51% drop in its stock price. Kaplan Fox & Kilsheimer LLP is investigati...

Market News
4 hours ago
Newsfile Corp
Bearish
news icon
Fulcrum Therapeutics faces investigation after stock halves due to halted sickle cell drug program.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $5.37B
  • Volume
    846,904
  • Sector
    Technology
  • 52W High
    $72.67
  • 52W Low
    $48.51
  • Typical Hold Time
    97 Days
  • Enterprise Value
    $4.75B
  • Div Yield
    2.51%
  • Trading Activity
    100% Sell | 0% Buy
$57.07
52W Low: $48.51
14 Jul 2026
52W High: $72.67
06 Oct 2025

Track Dolby Laboratories, Inc. (DLB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Dolby Laboratories, Inc. has traded between a low of $48.51 and a high of $72.67, highlighting its annual price range. Buy and sell Dolby Laboratories, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!